2017/05/15 by Stuart M. Fell, Shuijie Li, Karin Wallis +13
Biochemistry, Genetics and Molecular Biology · Medicine · #Cellular transport and secretion #Hippo pathway signaling and YAP/TAZ #Neuroblastoma Research and Treatments
paper · pdf · doi:10.1101/gad.297077.117
openalex publication_date 2017/05/15 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
We recently identified pathogenic KIF1B β mutations in sympathetic nervous system malignancies that are defective in developmental apoptosis. Here we deleted KIF1B β in the mouse sympathetic nervous system and observed impaired sympathetic nervous function and misexpression of genes required for sympathoadrenal lineage differentiation. We discovered that KIF1Bβ is required for nerve growth factor (NGF)-dependent neuronal differentiation through anterograde transport of the NGF receptor TRKA. Moreover, pathogenic KIF1B β mutations identified in neuroblastoma impair TRKA transport. Expression of neuronal differentiation markers is ablated in both KIF1B β-deficient mouse neuroblasts and human neuroblastomas that lack KIF1Bβ. Transcriptomic analyses show that unfavorable neuroblastomas resemble mouse sympathetic neuroblasts lacking KIF1Bβ independent of MYCN amplification and the loss of genes neighboring KIF1B on chromosome 1p36. Thus, defective precursor cell differentiation, a common trait of aggressive childhood malignancies, is a pathogenic effect of KIF1Bβ loss in neuroblastomas. Furthermore, neuropathy-associated KIF1Bβ mutations impede cargo transport, providing a direct link between neuroblastomas and neurodegeneration.